nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—CXCL8—urinary bladder cancer	0.356	0.774	CbGaD
Ketoprofen—PTGS2—urinary bladder cancer	0.104	0.226	CbGaD
Ketoprofen—SLC22A7—Fluorouracil—urinary bladder cancer	0.0457	0.135	CbGbCtD
Ketoprofen—ABCC4—Fluorouracil—urinary bladder cancer	0.0447	0.132	CbGbCtD
Ketoprofen—SLC22A11—Methotrexate—urinary bladder cancer	0.0265	0.0781	CbGbCtD
Ketoprofen—SLC22A7—Methotrexate—urinary bladder cancer	0.0252	0.0744	CbGbCtD
Ketoprofen—ABCC4—Methotrexate—urinary bladder cancer	0.0246	0.0727	CbGbCtD
Ketoprofen—PTGS2—Cisplatin—urinary bladder cancer	0.0223	0.0658	CbGbCtD
Ketoprofen—PTGS2—Etoposide—urinary bladder cancer	0.0219	0.0647	CbGbCtD
Ketoprofen—PTGS1—Etoposide—urinary bladder cancer	0.0185	0.0546	CbGbCtD
Ketoprofen—SLCO1A2—Methotrexate—urinary bladder cancer	0.0177	0.0522	CbGbCtD
Ketoprofen—ALB—Fluorouracil—urinary bladder cancer	0.0166	0.0489	CbGbCtD
Ketoprofen—SLC22A8—Methotrexate—urinary bladder cancer	0.0154	0.0454	CbGbCtD
Ketoprofen—CYP2C8—Fluorouracil—urinary bladder cancer	0.0128	0.0378	CbGbCtD
Ketoprofen—SLC22A6—Methotrexate—urinary bladder cancer	0.0107	0.0316	CbGbCtD
Ketoprofen—CYP2C8—Etoposide—urinary bladder cancer	0.0107	0.0315	CbGbCtD
Ketoprofen—ALB—Methotrexate—urinary bladder cancer	0.00913	0.0269	CbGbCtD
Ketoprofen—CYP2C9—Fluorouracil—urinary bladder cancer	0.00892	0.0263	CbGbCtD
Ketoprofen—CYP2C9—Cisplatin—urinary bladder cancer	0.00758	0.0224	CbGbCtD
Ketoprofen—SLC22A8—urine—urinary bladder cancer	0.00257	0.0923	CbGeAlD
Ketoprofen—CXCL8—prostate gland—urinary bladder cancer	0.00197	0.0709	CbGeAlD
Ketoprofen—CXCR1—lymph node—urinary bladder cancer	0.00177	0.0638	CbGeAlD
Ketoprofen—CYP2C9—urine—urinary bladder cancer	0.00167	0.06	CbGeAlD
Ketoprofen—CXCL8—smooth muscle tissue—urinary bladder cancer	0.0014	0.0502	CbGeAlD
Ketoprofen—CXCL8—urethra—urinary bladder cancer	0.00132	0.0475	CbGeAlD
Ketoprofen—SLC22A11—renal system—urinary bladder cancer	0.00111	0.04	CbGeAlD
Ketoprofen—SLC22A7—renal system—urinary bladder cancer	0.00109	0.0391	CbGeAlD
Ketoprofen—CXCL8—vagina—urinary bladder cancer	0.000973	0.035	CbGeAlD
Ketoprofen—ABCC4—prostate gland—urinary bladder cancer	0.000929	0.0334	CbGeAlD
Ketoprofen—SLC22A8—prostate gland—urinary bladder cancer	0.000922	0.0331	CbGeAlD
Ketoprofen—SLC22A11—female reproductive system—urinary bladder cancer	0.000892	0.0321	CbGeAlD
Ketoprofen—Suprofen—UGT2B7—urinary bladder cancer	0.000848	0.209	CrCbGaD
Ketoprofen—Naproxen—UGT2B7—urinary bladder cancer	0.000665	0.164	CrCbGaD
Ketoprofen—SLCO1A2—renal system—urinary bladder cancer	0.000658	0.0237	CbGeAlD
Ketoprofen—ABCC4—renal system—urinary bladder cancer	0.000633	0.0228	CbGeAlD
Ketoprofen—CXCL8—lymph node—urinary bladder cancer	0.00063	0.0226	CbGeAlD
Ketoprofen—SLC22A8—renal system—urinary bladder cancer	0.000628	0.0226	CbGeAlD
Ketoprofen—PTGS1—prostate gland—urinary bladder cancer	0.000547	0.0197	CbGeAlD
Ketoprofen—PTGS2—prostate gland—urinary bladder cancer	0.000523	0.0188	CbGeAlD
Ketoprofen—ABCC4—female reproductive system—urinary bladder cancer	0.000507	0.0182	CbGeAlD
Ketoprofen—Flurbiprofen—UGT2B7—urinary bladder cancer	0.000477	0.117	CrCbGaD
Ketoprofen—PTGS1—seminal vesicle—urinary bladder cancer	0.000463	0.0166	CbGeAlD
Ketoprofen—CYP2C8—renal system—urinary bladder cancer	0.00046	0.0165	CbGeAlD
Ketoprofen—PTGS2—seminal vesicle—urinary bladder cancer	0.000442	0.0159	CbGeAlD
Ketoprofen—PTGS1—epithelium—urinary bladder cancer	0.000402	0.0145	CbGeAlD
Ketoprofen—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000387	0.0139	CbGeAlD
Ketoprofen—PTGS2—epithelium—urinary bladder cancer	0.000384	0.0138	CbGeAlD
Ketoprofen—PTGS1—renal system—urinary bladder cancer	0.000373	0.0134	CbGeAlD
Ketoprofen—PTGS2—smooth muscle tissue—urinary bladder cancer	0.00037	0.0133	CbGeAlD
Ketoprofen—CYP2C8—female reproductive system—urinary bladder cancer	0.000368	0.0132	CbGeAlD
Ketoprofen—PTGS2—renal system—urinary bladder cancer	0.000356	0.0128	CbGeAlD
Ketoprofen—PTGS2—urethra—urinary bladder cancer	0.00035	0.0126	CbGeAlD
Ketoprofen—CYP2C8—vagina—urinary bladder cancer	0.000333	0.012	CbGeAlD
Ketoprofen—CYP2C9—female reproductive system—urinary bladder cancer	0.000327	0.0118	CbGeAlD
Ketoprofen—ALB—lymph node—urinary bladder cancer	0.000306	0.011	CbGeAlD
Ketoprofen—PTGS1—female reproductive system—urinary bladder cancer	0.000299	0.0107	CbGeAlD
Ketoprofen—ABCC4—lymph node—urinary bladder cancer	0.000297	0.0107	CbGeAlD
Ketoprofen—PTGS2—female reproductive system—urinary bladder cancer	0.000285	0.0103	CbGeAlD
Ketoprofen—PTGS1—vagina—urinary bladder cancer	0.00027	0.00971	CbGeAlD
Ketoprofen—PTGS2—vagina—urinary bladder cancer	0.000258	0.00928	CbGeAlD
Ketoprofen—Carprofen—PTGS2—urinary bladder cancer	0.000226	0.0557	CrCbGaD
Ketoprofen—Ketorolac—PTGS2—urinary bladder cancer	0.000226	0.0557	CrCbGaD
Ketoprofen—Bromfenac—PTGS2—urinary bladder cancer	0.000217	0.0534	CrCbGaD
Ketoprofen—Tiaprofenic acid—PTGS2—urinary bladder cancer	0.000184	0.0454	CrCbGaD
Ketoprofen—Nepafenac—PTGS2—urinary bladder cancer	0.000175	0.0432	CrCbGaD
Ketoprofen—PTGS1—lymph node—urinary bladder cancer	0.000175	0.00628	CbGeAlD
Ketoprofen—Magnesium salicylate—PTGS2—urinary bladder cancer	0.000171	0.0422	CrCbGaD
Ketoprofen—Fenbufen—PTGS2—urinary bladder cancer	0.000168	0.0413	CrCbGaD
Ketoprofen—PTGS2—lymph node—urinary bladder cancer	0.000167	0.006	CbGeAlD
Ketoprofen—Salsalate—PTGS2—urinary bladder cancer	0.000146	0.0359	CrCbGaD
Ketoprofen—Suprofen—PTGS2—urinary bladder cancer	0.00014	0.0344	CrCbGaD
Ketoprofen—Fenoprofen—PTGS2—urinary bladder cancer	0.00012	0.0296	CrCbGaD
Ketoprofen—Mefenamic acid—PTGS2—urinary bladder cancer	0.000112	0.0275	CrCbGaD
Ketoprofen—Naproxen—PTGS2—urinary bladder cancer	0.00011	0.027	CrCbGaD
Ketoprofen—Dizziness—Thiotepa—urinary bladder cancer	9.63e-05	0.000859	CcSEcCtD
Ketoprofen—Stomatitis—Methotrexate—urinary bladder cancer	9.58e-05	0.000854	CcSEcCtD
Ketoprofen—Urticaria—Fluorouracil—urinary bladder cancer	9.57e-05	0.000854	CcSEcCtD
Ketoprofen—Conjunctivitis—Methotrexate—urinary bladder cancer	9.55e-05	0.000852	CcSEcCtD
Ketoprofen—Asthma—Doxorubicin—urinary bladder cancer	9.54e-05	0.000851	CcSEcCtD
Ketoprofen—Sweating—Methotrexate—urinary bladder cancer	9.42e-05	0.00084	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Epirubicin—urinary bladder cancer	9.41e-05	0.00084	CcSEcCtD
Ketoprofen—Feeling abnormal—Cisplatin—urinary bladder cancer	9.41e-05	0.000839	CcSEcCtD
Ketoprofen—Paraesthesia—Etoposide—urinary bladder cancer	9.39e-05	0.000838	CcSEcCtD
Ketoprofen—Weight increased—Epirubicin—urinary bladder cancer	9.38e-05	0.000837	CcSEcCtD
Ketoprofen—Haematuria—Methotrexate—urinary bladder cancer	9.37e-05	0.000836	CcSEcCtD
Ketoprofen—Pancreatitis—Doxorubicin—urinary bladder cancer	9.35e-05	0.000835	CcSEcCtD
Ketoprofen—Weight decreased—Epirubicin—urinary bladder cancer	9.33e-05	0.000832	CcSEcCtD
Ketoprofen—Dyspnoea—Etoposide—urinary bladder cancer	9.33e-05	0.000832	CcSEcCtD
Ketoprofen—Somnolence—Etoposide—urinary bladder cancer	9.3e-05	0.00083	CcSEcCtD
Ketoprofen—Epistaxis—Methotrexate—urinary bladder cancer	9.27e-05	0.000827	CcSEcCtD
Ketoprofen—Vomiting—Thiotepa—urinary bladder cancer	9.26e-05	0.000826	CcSEcCtD
Ketoprofen—Drowsiness—Epirubicin—urinary bladder cancer	9.19e-05	0.00082	CcSEcCtD
Ketoprofen—Rash—Thiotepa—urinary bladder cancer	9.18e-05	0.000819	CcSEcCtD
Ketoprofen—Dermatitis—Thiotepa—urinary bladder cancer	9.17e-05	0.000818	CcSEcCtD
Ketoprofen—Agranulocytosis—Methotrexate—urinary bladder cancer	9.17e-05	0.000818	CcSEcCtD
Ketoprofen—Headache—Thiotepa—urinary bladder cancer	9.12e-05	0.000814	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	9.12e-05	0.000813	CcSEcCtD
Ketoprofen—Decreased appetite—Etoposide—urinary bladder cancer	9.09e-05	0.000811	CcSEcCtD
Ketoprofen—Renal failure—Epirubicin—urinary bladder cancer	9.04e-05	0.000806	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Etoposide—urinary bladder cancer	9.03e-05	0.000806	CcSEcCtD
Ketoprofen—Fatigue—Etoposide—urinary bladder cancer	9.02e-05	0.000805	CcSEcCtD
Ketoprofen—Jaundice—Epirubicin—urinary bladder cancer	8.96e-05	0.0008	CcSEcCtD
Ketoprofen—Stomatitis—Epirubicin—urinary bladder cancer	8.96e-05	0.0008	CcSEcCtD
Ketoprofen—Constipation—Etoposide—urinary bladder cancer	8.95e-05	0.000798	CcSEcCtD
Ketoprofen—Conjunctivitis—Epirubicin—urinary bladder cancer	8.94e-05	0.000797	CcSEcCtD
Ketoprofen—Hypersensitivity—Fluorouracil—urinary bladder cancer	8.87e-05	0.000792	CcSEcCtD
Ketoprofen—Hepatitis—Methotrexate—urinary bladder cancer	8.82e-05	0.000787	CcSEcCtD
Ketoprofen—Sweating—Epirubicin—urinary bladder cancer	8.81e-05	0.000786	CcSEcCtD
Ketoprofen—Asthenia—Gemcitabine—urinary bladder cancer	8.79e-05	0.000784	CcSEcCtD
Ketoprofen—Haematuria—Epirubicin—urinary bladder cancer	8.77e-05	0.000782	CcSEcCtD
Ketoprofen—Pharyngitis—Methotrexate—urinary bladder cancer	8.75e-05	0.000781	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	8.71e-05	0.000777	CcSEcCtD
Ketoprofen—Weight increased—Doxorubicin—urinary bladder cancer	8.68e-05	0.000775	CcSEcCtD
Ketoprofen—Epistaxis—Epirubicin—urinary bladder cancer	8.67e-05	0.000774	CcSEcCtD
Ketoprofen—Pruritus—Gemcitabine—urinary bladder cancer	8.67e-05	0.000773	CcSEcCtD
Ketoprofen—Nausea—Thiotepa—urinary bladder cancer	8.65e-05	0.000772	CcSEcCtD
Ketoprofen—Weight decreased—Doxorubicin—urinary bladder cancer	8.63e-05	0.00077	CcSEcCtD
Ketoprofen—Feeling abnormal—Etoposide—urinary bladder cancer	8.62e-05	0.000769	CcSEcCtD
Ketoprofen—Agranulocytosis—Epirubicin—urinary bladder cancer	8.58e-05	0.000765	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Etoposide—urinary bladder cancer	8.55e-05	0.000763	CcSEcCtD
Ketoprofen—Pruritus—Fluorouracil—urinary bladder cancer	8.52e-05	0.00076	CcSEcCtD
Ketoprofen—Drowsiness—Doxorubicin—urinary bladder cancer	8.51e-05	0.000759	CcSEcCtD
Ketoprofen—Visual impairment—Methotrexate—urinary bladder cancer	8.5e-05	0.000758	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	8.43e-05	0.000752	CcSEcCtD
Ketoprofen—Hypersensitivity—Cisplatin—urinary bladder cancer	8.41e-05	0.000751	CcSEcCtD
Ketoprofen—Diarrhoea—Gemcitabine—urinary bladder cancer	8.38e-05	0.000748	CcSEcCtD
Ketoprofen—Renal failure—Doxorubicin—urinary bladder cancer	8.36e-05	0.000746	CcSEcCtD
Ketoprofen—Erythema multiforme—Methotrexate—urinary bladder cancer	8.34e-05	0.000744	CcSEcCtD
Ketoprofen—Urticaria—Etoposide—urinary bladder cancer	8.31e-05	0.000741	CcSEcCtD
Ketoprofen—Jaundice—Doxorubicin—urinary bladder cancer	8.29e-05	0.00074	CcSEcCtD
Ketoprofen—Stomatitis—Doxorubicin—urinary bladder cancer	8.29e-05	0.00074	CcSEcCtD
Ketoprofen—Rhinitis—Epirubicin—urinary bladder cancer	8.27e-05	0.000738	CcSEcCtD
Ketoprofen—Abdominal pain—Etoposide—urinary bladder cancer	8.27e-05	0.000738	CcSEcCtD
Ketoprofen—Conjunctivitis—Doxorubicin—urinary bladder cancer	8.27e-05	0.000738	CcSEcCtD
Ketoprofen—Hepatitis—Epirubicin—urinary bladder cancer	8.25e-05	0.000736	CcSEcCtD
Ketoprofen—Diarrhoea—Fluorouracil—urinary bladder cancer	8.24e-05	0.000735	CcSEcCtD
Ketoprofen—Tinnitus—Methotrexate—urinary bladder cancer	8.22e-05	0.000734	CcSEcCtD
Ketoprofen—Asthenia—Cisplatin—urinary bladder cancer	8.19e-05	0.000731	CcSEcCtD
Ketoprofen—Pharyngitis—Epirubicin—urinary bladder cancer	8.19e-05	0.000731	CcSEcCtD
Ketoprofen—Sweating—Doxorubicin—urinary bladder cancer	8.16e-05	0.000728	CcSEcCtD
Ketoprofen—Haematuria—Doxorubicin—urinary bladder cancer	8.11e-05	0.000724	CcSEcCtD
Ketoprofen—Epistaxis—Doxorubicin—urinary bladder cancer	8.02e-05	0.000716	CcSEcCtD
Ketoprofen—Dizziness—Fluorouracil—urinary bladder cancer	7.97e-05	0.000711	CcSEcCtD
Ketoprofen—Visual impairment—Epirubicin—urinary bladder cancer	7.95e-05	0.00071	CcSEcCtD
Ketoprofen—Agranulocytosis—Doxorubicin—urinary bladder cancer	7.94e-05	0.000708	CcSEcCtD
Ketoprofen—Chills—Methotrexate—urinary bladder cancer	7.91e-05	0.000706	CcSEcCtD
Ketoprofen—Flurbiprofen—PTGS2—urinary bladder cancer	7.86e-05	0.0193	CrCbGaD
Ketoprofen—Diarrhoea—Cisplatin—urinary bladder cancer	7.81e-05	0.000697	CcSEcCtD
Ketoprofen—Erythema multiforme—Epirubicin—urinary bladder cancer	7.8e-05	0.000696	CcSEcCtD
Ketoprofen—Alopecia—Methotrexate—urinary bladder cancer	7.79e-05	0.000695	CcSEcCtD
Ketoprofen—Vomiting—Gemcitabine—urinary bladder cancer	7.79e-05	0.000695	CcSEcCtD
Ketoprofen—Rash—Gemcitabine—urinary bladder cancer	7.72e-05	0.000689	CcSEcCtD
Ketoprofen—Dermatitis—Gemcitabine—urinary bladder cancer	7.72e-05	0.000688	CcSEcCtD
Ketoprofen—Hypersensitivity—Etoposide—urinary bladder cancer	7.71e-05	0.000688	CcSEcCtD
Ketoprofen—Tinnitus—Epirubicin—urinary bladder cancer	7.7e-05	0.000687	CcSEcCtD
Ketoprofen—Erythema—Methotrexate—urinary bladder cancer	7.68e-05	0.000685	CcSEcCtD
Ketoprofen—Headache—Gemcitabine—urinary bladder cancer	7.67e-05	0.000685	CcSEcCtD
Ketoprofen—Flushing—Epirubicin—urinary bladder cancer	7.66e-05	0.000683	CcSEcCtD
Ketoprofen—Vomiting—Fluorouracil—urinary bladder cancer	7.66e-05	0.000683	CcSEcCtD
Ketoprofen—Rhinitis—Doxorubicin—urinary bladder cancer	7.66e-05	0.000683	CcSEcCtD
Ketoprofen—Hepatitis—Doxorubicin—urinary bladder cancer	7.64e-05	0.000681	CcSEcCtD
Ketoprofen—Rash—Fluorouracil—urinary bladder cancer	7.6e-05	0.000678	CcSEcCtD
Ketoprofen—Dermatitis—Fluorouracil—urinary bladder cancer	7.59e-05	0.000677	CcSEcCtD
Ketoprofen—Pharyngitis—Doxorubicin—urinary bladder cancer	7.58e-05	0.000676	CcSEcCtD
Ketoprofen—Headache—Fluorouracil—urinary bladder cancer	7.55e-05	0.000673	CcSEcCtD
Ketoprofen—Dysgeusia—Methotrexate—urinary bladder cancer	7.52e-05	0.000671	CcSEcCtD
Ketoprofen—Asthenia—Etoposide—urinary bladder cancer	7.51e-05	0.00067	CcSEcCtD
Ketoprofen—Chills—Epirubicin—urinary bladder cancer	7.41e-05	0.000661	CcSEcCtD
Ketoprofen—Pruritus—Etoposide—urinary bladder cancer	7.4e-05	0.00066	CcSEcCtD
Ketoprofen—Arrhythmia—Epirubicin—urinary bladder cancer	7.37e-05	0.000658	CcSEcCtD
Ketoprofen—Visual impairment—Doxorubicin—urinary bladder cancer	7.36e-05	0.000657	CcSEcCtD
Ketoprofen—Alopecia—Epirubicin—urinary bladder cancer	7.29e-05	0.000651	CcSEcCtD
Ketoprofen—Nausea—Gemcitabine—urinary bladder cancer	7.28e-05	0.000649	CcSEcCtD
Ketoprofen—Vomiting—Cisplatin—urinary bladder cancer	7.26e-05	0.000648	CcSEcCtD
Ketoprofen—Erythema multiforme—Doxorubicin—urinary bladder cancer	7.22e-05	0.000644	CcSEcCtD
Ketoprofen—Rash—Cisplatin—urinary bladder cancer	7.2e-05	0.000642	CcSEcCtD
Ketoprofen—Dermatitis—Cisplatin—urinary bladder cancer	7.19e-05	0.000642	CcSEcCtD
Ketoprofen—Erythema—Epirubicin—urinary bladder cancer	7.19e-05	0.000641	CcSEcCtD
Ketoprofen—Diarrhoea—Etoposide—urinary bladder cancer	7.16e-05	0.000639	CcSEcCtD
Ketoprofen—Nausea—Fluorouracil—urinary bladder cancer	7.15e-05	0.000638	CcSEcCtD
Ketoprofen—Ill-defined disorder—Methotrexate—urinary bladder cancer	7.12e-05	0.000636	CcSEcCtD
Ketoprofen—Tinnitus—Doxorubicin—urinary bladder cancer	7.12e-05	0.000635	CcSEcCtD
Ketoprofen—Anaemia—Methotrexate—urinary bladder cancer	7.1e-05	0.000633	CcSEcCtD
Ketoprofen—Flushing—Doxorubicin—urinary bladder cancer	7.09e-05	0.000632	CcSEcCtD
Ketoprofen—Flatulence—Epirubicin—urinary bladder cancer	7.08e-05	0.000632	CcSEcCtD
Ketoprofen—Tension—Epirubicin—urinary bladder cancer	7.05e-05	0.000629	CcSEcCtD
Ketoprofen—Dysgeusia—Epirubicin—urinary bladder cancer	7.04e-05	0.000628	CcSEcCtD
Ketoprofen—Nervousness—Epirubicin—urinary bladder cancer	6.98e-05	0.000623	CcSEcCtD
Ketoprofen—Malaise—Methotrexate—urinary bladder cancer	6.92e-05	0.000618	CcSEcCtD
Ketoprofen—Dizziness—Etoposide—urinary bladder cancer	6.92e-05	0.000617	CcSEcCtD
Ketoprofen—Vertigo—Methotrexate—urinary bladder cancer	6.9e-05	0.000615	CcSEcCtD
Ketoprofen—Chills—Doxorubicin—urinary bladder cancer	6.85e-05	0.000611	CcSEcCtD
Ketoprofen—Arrhythmia—Doxorubicin—urinary bladder cancer	6.82e-05	0.000609	CcSEcCtD
Ketoprofen—Nausea—Cisplatin—urinary bladder cancer	6.78e-05	0.000605	CcSEcCtD
Ketoprofen—Alopecia—Doxorubicin—urinary bladder cancer	6.75e-05	0.000602	CcSEcCtD
Ketoprofen—Ill-defined disorder—Epirubicin—urinary bladder cancer	6.67e-05	0.000595	CcSEcCtD
Ketoprofen—Convulsion—Methotrexate—urinary bladder cancer	6.65e-05	0.000593	CcSEcCtD
Ketoprofen—Vomiting—Etoposide—urinary bladder cancer	6.65e-05	0.000593	CcSEcCtD
Ketoprofen—Erythema—Doxorubicin—urinary bladder cancer	6.65e-05	0.000593	CcSEcCtD
Ketoprofen—Anaemia—Epirubicin—urinary bladder cancer	6.64e-05	0.000592	CcSEcCtD
Ketoprofen—Rash—Etoposide—urinary bladder cancer	6.6e-05	0.000588	CcSEcCtD
Ketoprofen—Dermatitis—Etoposide—urinary bladder cancer	6.59e-05	0.000588	CcSEcCtD
Ketoprofen—Headache—Etoposide—urinary bladder cancer	6.55e-05	0.000585	CcSEcCtD
Ketoprofen—Flatulence—Doxorubicin—urinary bladder cancer	6.55e-05	0.000584	CcSEcCtD
Ketoprofen—Myalgia—Methotrexate—urinary bladder cancer	6.54e-05	0.000583	CcSEcCtD
Ketoprofen—Tension—Doxorubicin—urinary bladder cancer	6.52e-05	0.000582	CcSEcCtD
Ketoprofen—Dysgeusia—Doxorubicin—urinary bladder cancer	6.51e-05	0.000581	CcSEcCtD
Ketoprofen—Malaise—Epirubicin—urinary bladder cancer	6.48e-05	0.000578	CcSEcCtD
Ketoprofen—Discomfort—Methotrexate—urinary bladder cancer	6.46e-05	0.000576	CcSEcCtD
Ketoprofen—Nervousness—Doxorubicin—urinary bladder cancer	6.46e-05	0.000576	CcSEcCtD
Ketoprofen—Vertigo—Epirubicin—urinary bladder cancer	6.46e-05	0.000576	CcSEcCtD
Ketoprofen—Palpitations—Epirubicin—urinary bladder cancer	6.35e-05	0.000566	CcSEcCtD
Ketoprofen—Confusional state—Methotrexate—urinary bladder cancer	6.32e-05	0.000564	CcSEcCtD
Ketoprofen—Anaphylactic shock—Methotrexate—urinary bladder cancer	6.27e-05	0.000559	CcSEcCtD
Ketoprofen—Convulsion—Epirubicin—urinary bladder cancer	6.23e-05	0.000555	CcSEcCtD
Ketoprofen—Infection—Methotrexate—urinary bladder cancer	6.23e-05	0.000555	CcSEcCtD
Ketoprofen—Nausea—Etoposide—urinary bladder cancer	6.21e-05	0.000554	CcSEcCtD
Ketoprofen—Hypertension—Epirubicin—urinary bladder cancer	6.2e-05	0.000553	CcSEcCtD
Ketoprofen—Ill-defined disorder—Doxorubicin—urinary bladder cancer	6.17e-05	0.00055	CcSEcCtD
Ketoprofen—Anaemia—Doxorubicin—urinary bladder cancer	6.14e-05	0.000548	CcSEcCtD
Ketoprofen—Thrombocytopenia—Methotrexate—urinary bladder cancer	6.14e-05	0.000547	CcSEcCtD
Ketoprofen—Myalgia—Epirubicin—urinary bladder cancer	6.12e-05	0.000546	CcSEcCtD
Ketoprofen—Anxiety—Epirubicin—urinary bladder cancer	6.1e-05	0.000544	CcSEcCtD
Ketoprofen—Hyperhidrosis—Methotrexate—urinary bladder cancer	6.06e-05	0.00054	CcSEcCtD
Ketoprofen—Discomfort—Epirubicin—urinary bladder cancer	6.04e-05	0.000539	CcSEcCtD
Ketoprofen—Malaise—Doxorubicin—urinary bladder cancer	6e-05	0.000535	CcSEcCtD
Ketoprofen—Dry mouth—Epirubicin—urinary bladder cancer	5.98e-05	0.000534	CcSEcCtD
Ketoprofen—Vertigo—Doxorubicin—urinary bladder cancer	5.97e-05	0.000533	CcSEcCtD
Ketoprofen—Anorexia—Methotrexate—urinary bladder cancer	5.97e-05	0.000533	CcSEcCtD
Ketoprofen—Confusional state—Epirubicin—urinary bladder cancer	5.91e-05	0.000527	CcSEcCtD
Ketoprofen—Palpitations—Doxorubicin—urinary bladder cancer	5.88e-05	0.000524	CcSEcCtD
Ketoprofen—Anaphylactic shock—Epirubicin—urinary bladder cancer	5.86e-05	0.000523	CcSEcCtD
Ketoprofen—Oedema—Epirubicin—urinary bladder cancer	5.86e-05	0.000523	CcSEcCtD
Ketoprofen—Infection—Epirubicin—urinary bladder cancer	5.83e-05	0.00052	CcSEcCtD
Ketoprofen—Shock—Epirubicin—urinary bladder cancer	5.77e-05	0.000515	CcSEcCtD
Ketoprofen—Convulsion—Doxorubicin—urinary bladder cancer	5.76e-05	0.000514	CcSEcCtD
Ketoprofen—Thrombocytopenia—Epirubicin—urinary bladder cancer	5.74e-05	0.000512	CcSEcCtD
Ketoprofen—Hypertension—Doxorubicin—urinary bladder cancer	5.74e-05	0.000512	CcSEcCtD
Ketoprofen—Tachycardia—Epirubicin—urinary bladder cancer	5.72e-05	0.000511	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	5.71e-05	0.000509	CcSEcCtD
Ketoprofen—Hyperhidrosis—Epirubicin—urinary bladder cancer	5.67e-05	0.000506	CcSEcCtD
Ketoprofen—Insomnia—Methotrexate—urinary bladder cancer	5.67e-05	0.000506	CcSEcCtD
Ketoprofen—Myalgia—Doxorubicin—urinary bladder cancer	5.66e-05	0.000505	CcSEcCtD
Ketoprofen—Anxiety—Doxorubicin—urinary bladder cancer	5.64e-05	0.000503	CcSEcCtD
Ketoprofen—Paraesthesia—Methotrexate—urinary bladder cancer	5.63e-05	0.000502	CcSEcCtD
Ketoprofen—Discomfort—Doxorubicin—urinary bladder cancer	5.59e-05	0.000499	CcSEcCtD
Ketoprofen—Anorexia—Epirubicin—urinary bladder cancer	5.59e-05	0.000499	CcSEcCtD
Ketoprofen—Dyspnoea—Methotrexate—urinary bladder cancer	5.59e-05	0.000498	CcSEcCtD
Ketoprofen—Somnolence—Methotrexate—urinary bladder cancer	5.57e-05	0.000497	CcSEcCtD
Ketoprofen—Dry mouth—Doxorubicin—urinary bladder cancer	5.54e-05	0.000494	CcSEcCtD
Ketoprofen—Dyspepsia—Methotrexate—urinary bladder cancer	5.52e-05	0.000492	CcSEcCtD
Ketoprofen—Confusional state—Doxorubicin—urinary bladder cancer	5.47e-05	0.000488	CcSEcCtD
Ketoprofen—Decreased appetite—Methotrexate—urinary bladder cancer	5.45e-05	0.000486	CcSEcCtD
Ketoprofen—Oedema—Doxorubicin—urinary bladder cancer	5.43e-05	0.000484	CcSEcCtD
Ketoprofen—Anaphylactic shock—Doxorubicin—urinary bladder cancer	5.43e-05	0.000484	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	5.41e-05	0.000483	CcSEcCtD
Ketoprofen—Fatigue—Methotrexate—urinary bladder cancer	5.4e-05	0.000482	CcSEcCtD
Ketoprofen—Infection—Doxorubicin—urinary bladder cancer	5.39e-05	0.000481	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	5.34e-05	0.000477	CcSEcCtD
Ketoprofen—Shock—Doxorubicin—urinary bladder cancer	5.34e-05	0.000476	CcSEcCtD
Ketoprofen—Thrombocytopenia—Doxorubicin—urinary bladder cancer	5.31e-05	0.000474	CcSEcCtD
Ketoprofen—Insomnia—Epirubicin—urinary bladder cancer	5.3e-05	0.000473	CcSEcCtD
Ketoprofen—Tachycardia—Doxorubicin—urinary bladder cancer	5.3e-05	0.000472	CcSEcCtD
Ketoprofen—Paraesthesia—Epirubicin—urinary bladder cancer	5.27e-05	0.00047	CcSEcCtD
Ketoprofen—Hyperhidrosis—Doxorubicin—urinary bladder cancer	5.25e-05	0.000468	CcSEcCtD
Ketoprofen—Dyspnoea—Epirubicin—urinary bladder cancer	5.23e-05	0.000466	CcSEcCtD
Ketoprofen—Somnolence—Epirubicin—urinary bladder cancer	5.21e-05	0.000465	CcSEcCtD
Ketoprofen—Anorexia—Doxorubicin—urinary bladder cancer	5.17e-05	0.000461	CcSEcCtD
Ketoprofen—Feeling abnormal—Methotrexate—urinary bladder cancer	5.16e-05	0.000461	CcSEcCtD
Ketoprofen—Dyspepsia—Epirubicin—urinary bladder cancer	5.16e-05	0.00046	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Methotrexate—urinary bladder cancer	5.12e-05	0.000457	CcSEcCtD
Ketoprofen—Decreased appetite—Epirubicin—urinary bladder cancer	5.1e-05	0.000455	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	5.06e-05	0.000452	CcSEcCtD
Ketoprofen—Fatigue—Epirubicin—urinary bladder cancer	5.06e-05	0.000451	CcSEcCtD
Ketoprofen—Constipation—Epirubicin—urinary bladder cancer	5.01e-05	0.000447	CcSEcCtD
Ketoprofen—Urticaria—Methotrexate—urinary bladder cancer	4.98e-05	0.000444	CcSEcCtD
Ketoprofen—Abdominal pain—Methotrexate—urinary bladder cancer	4.95e-05	0.000442	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	4.94e-05	0.000441	CcSEcCtD
Ketoprofen—Insomnia—Doxorubicin—urinary bladder cancer	4.91e-05	0.000438	CcSEcCtD
Ketoprofen—Paraesthesia—Doxorubicin—urinary bladder cancer	4.87e-05	0.000435	CcSEcCtD
Ketoprofen—Dyspnoea—Doxorubicin—urinary bladder cancer	4.84e-05	0.000432	CcSEcCtD
Ketoprofen—Feeling abnormal—Epirubicin—urinary bladder cancer	4.83e-05	0.000431	CcSEcCtD
Ketoprofen—Somnolence—Doxorubicin—urinary bladder cancer	4.82e-05	0.00043	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Epirubicin—urinary bladder cancer	4.8e-05	0.000428	CcSEcCtD
Ketoprofen—Dyspepsia—Doxorubicin—urinary bladder cancer	4.78e-05	0.000426	CcSEcCtD
Ketoprofen—Decreased appetite—Doxorubicin—urinary bladder cancer	4.72e-05	0.000421	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	4.68e-05	0.000418	CcSEcCtD
Ketoprofen—Fatigue—Doxorubicin—urinary bladder cancer	4.68e-05	0.000417	CcSEcCtD
Ketoprofen—Urticaria—Epirubicin—urinary bladder cancer	4.66e-05	0.000416	CcSEcCtD
Ketoprofen—Constipation—Doxorubicin—urinary bladder cancer	4.64e-05	0.000414	CcSEcCtD
Ketoprofen—Abdominal pain—Epirubicin—urinary bladder cancer	4.64e-05	0.000414	CcSEcCtD
Ketoprofen—Hypersensitivity—Methotrexate—urinary bladder cancer	4.62e-05	0.000412	CcSEcCtD
Ketoprofen—Asthenia—Methotrexate—urinary bladder cancer	4.5e-05	0.000401	CcSEcCtD
Ketoprofen—Feeling abnormal—Doxorubicin—urinary bladder cancer	4.47e-05	0.000399	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	4.44e-05	0.000396	CcSEcCtD
Ketoprofen—Pruritus—Methotrexate—urinary bladder cancer	4.43e-05	0.000395	CcSEcCtD
Ketoprofen—Hypersensitivity—Epirubicin—urinary bladder cancer	4.32e-05	0.000385	CcSEcCtD
Ketoprofen—Urticaria—Doxorubicin—urinary bladder cancer	4.31e-05	0.000385	CcSEcCtD
Ketoprofen—Abdominal pain—Doxorubicin—urinary bladder cancer	4.29e-05	0.000383	CcSEcCtD
Ketoprofen—Diarrhoea—Methotrexate—urinary bladder cancer	4.29e-05	0.000382	CcSEcCtD
Ketoprofen—Asthenia—Epirubicin—urinary bladder cancer	4.21e-05	0.000375	CcSEcCtD
Ketoprofen—Pruritus—Epirubicin—urinary bladder cancer	4.15e-05	0.00037	CcSEcCtD
Ketoprofen—Dizziness—Methotrexate—urinary bladder cancer	4.14e-05	0.00037	CcSEcCtD
Ketoprofen—Diarrhoea—Epirubicin—urinary bladder cancer	4.01e-05	0.000358	CcSEcCtD
Ketoprofen—Hypersensitivity—Doxorubicin—urinary bladder cancer	4e-05	0.000357	CcSEcCtD
Ketoprofen—Vomiting—Methotrexate—urinary bladder cancer	3.98e-05	0.000355	CcSEcCtD
Ketoprofen—Rash—Methotrexate—urinary bladder cancer	3.95e-05	0.000352	CcSEcCtD
Ketoprofen—Dermatitis—Methotrexate—urinary bladder cancer	3.95e-05	0.000352	CcSEcCtD
Ketoprofen—Headache—Methotrexate—urinary bladder cancer	3.93e-05	0.00035	CcSEcCtD
Ketoprofen—Asthenia—Doxorubicin—urinary bladder cancer	3.89e-05	0.000347	CcSEcCtD
Ketoprofen—Dizziness—Epirubicin—urinary bladder cancer	3.88e-05	0.000346	CcSEcCtD
Ketoprofen—Pruritus—Doxorubicin—urinary bladder cancer	3.84e-05	0.000342	CcSEcCtD
Ketoprofen—Vomiting—Epirubicin—urinary bladder cancer	3.73e-05	0.000333	CcSEcCtD
Ketoprofen—Nausea—Methotrexate—urinary bladder cancer	3.72e-05	0.000332	CcSEcCtD
Ketoprofen—Diarrhoea—Doxorubicin—urinary bladder cancer	3.71e-05	0.000331	CcSEcCtD
Ketoprofen—Rash—Epirubicin—urinary bladder cancer	3.7e-05	0.00033	CcSEcCtD
Ketoprofen—Dermatitis—Epirubicin—urinary bladder cancer	3.69e-05	0.00033	CcSEcCtD
Ketoprofen—Headache—Epirubicin—urinary bladder cancer	3.67e-05	0.000328	CcSEcCtD
Ketoprofen—Dizziness—Doxorubicin—urinary bladder cancer	3.59e-05	0.00032	CcSEcCtD
Ketoprofen—Nausea—Epirubicin—urinary bladder cancer	3.48e-05	0.000311	CcSEcCtD
Ketoprofen—Vomiting—Doxorubicin—urinary bladder cancer	3.45e-05	0.000308	CcSEcCtD
Ketoprofen—Rash—Doxorubicin—urinary bladder cancer	3.42e-05	0.000305	CcSEcCtD
Ketoprofen—Dermatitis—Doxorubicin—urinary bladder cancer	3.42e-05	0.000305	CcSEcCtD
Ketoprofen—Headache—Doxorubicin—urinary bladder cancer	3.4e-05	0.000303	CcSEcCtD
Ketoprofen—Nausea—Doxorubicin—urinary bladder cancer	3.22e-05	0.000288	CcSEcCtD
Ketoprofen—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	1.83e-05	0.00032	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.82e-05	0.000317	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NAT2—urinary bladder cancer	1.81e-05	0.000316	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.8e-05	0.000315	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—LIG1—urinary bladder cancer	1.8e-05	0.000314	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.79e-05	0.000312	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	1.76e-05	0.000307	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP4B1—urinary bladder cancer	1.75e-05	0.000305	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.74e-05	0.000304	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	1.74e-05	0.000303	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NAT1—urinary bladder cancer	1.74e-05	0.000303	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—ERBB2—urinary bladder cancer	1.73e-05	0.000302	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.73e-05	0.000301	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	1.71e-05	0.000299	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.71e-05	0.000298	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IFNA2—urinary bladder cancer	1.67e-05	0.000291	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	1.66e-05	0.00029	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC19A1—urinary bladder cancer	1.65e-05	0.000288	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CXCL8—urinary bladder cancer	1.64e-05	0.000286	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—IL2—urinary bladder cancer	1.64e-05	0.000285	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—HRAS—urinary bladder cancer	1.63e-05	0.000284	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.62e-05	0.000283	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	1.62e-05	0.000282	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PRSS3—urinary bladder cancer	1.61e-05	0.000281	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.59e-05	0.000278	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—TYMP—urinary bladder cancer	1.59e-05	0.000277	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	1.59e-05	0.000277	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—RHOA—urinary bladder cancer	1.57e-05	0.000274	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL2—urinary bladder cancer	1.57e-05	0.000274	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—RRM2—urinary bladder cancer	1.56e-05	0.000273	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.56e-05	0.000272	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	1.53e-05	0.000268	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCND1—urinary bladder cancer	1.53e-05	0.000267	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.53e-05	0.000266	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.53e-05	0.000266	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—S100B—urinary bladder cancer	1.51e-05	0.000263	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.49e-05	0.00026	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MMP9—urinary bladder cancer	1.49e-05	0.000259	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.48e-05	0.000258	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PTEN—urinary bladder cancer	1.48e-05	0.000257	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—EP300—urinary bladder cancer	1.47e-05	0.000256	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.45e-05	0.000253	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—HPGDS—urinary bladder cancer	1.45e-05	0.000252	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ENO2—urinary bladder cancer	1.45e-05	0.000252	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.44e-05	0.000251	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.44e-05	0.000251	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NAT2—urinary bladder cancer	1.44e-05	0.000251	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	1.44e-05	0.00025	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	1.43e-05	0.00025	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—RHOA—urinary bladder cancer	1.43e-05	0.000249	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—SRC—urinary bladder cancer	1.43e-05	0.000249	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EP300—urinary bladder cancer	1.41e-05	0.000246	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GSTT1—urinary bladder cancer	1.4e-05	0.000245	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.38e-05	0.000241	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ENO2—urinary bladder cancer	1.37e-05	0.000239	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—SRC—urinary bladder cancer	1.37e-05	0.000239	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NCOR1—urinary bladder cancer	1.36e-05	0.000236	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.35e-05	0.000236	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—IL2—urinary bladder cancer	1.32e-05	0.00023	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.32e-05	0.00023	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—RBX1—urinary bladder cancer	1.3e-05	0.000227	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.3e-05	0.000226	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.3e-05	0.000226	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TYMP—urinary bladder cancer	1.29e-05	0.000226	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.29e-05	0.000225	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TYMP—urinary bladder cancer	1.29e-05	0.000224	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.28e-05	0.000223	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	1.28e-05	0.000223	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	1.25e-05	0.000219	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.24e-05	0.000217	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—RRM2—urinary bladder cancer	1.24e-05	0.000216	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.24e-05	0.000216	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.24e-05	0.000215	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MYC—urinary bladder cancer	1.23e-05	0.000214	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EGFR—urinary bladder cancer	1.2e-05	0.000209	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL2—urinary bladder cancer	1.2e-05	0.000209	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TERT—urinary bladder cancer	1.19e-05	0.000208	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	1.19e-05	0.000207	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PLAU—urinary bladder cancer	1.18e-05	0.000206	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—KRAS—urinary bladder cancer	1.18e-05	0.000206	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	1.18e-05	0.000205	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	1.18e-05	0.000205	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NAT2—urinary bladder cancer	1.17e-05	0.000204	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NQO1—urinary bladder cancer	1.17e-05	0.000204	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—JAG1—urinary bladder cancer	1.16e-05	0.000203	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NAT2—urinary bladder cancer	1.16e-05	0.000203	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ENO2—urinary bladder cancer	1.15e-05	0.0002	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—HPGDS—urinary bladder cancer	1.15e-05	0.0002	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.14e-05	0.000199	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KRAS—urinary bladder cancer	1.13e-05	0.000198	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.13e-05	0.000197	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	1.13e-05	0.000196	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTT1—urinary bladder cancer	1.12e-05	0.000194	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	1.11e-05	0.000193	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.1e-05	0.000191	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FGFR3—urinary bladder cancer	1.1e-05	0.000191	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ESR1—urinary bladder cancer	1.06e-05	0.000186	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.06e-05	0.000184	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.05e-05	0.000184	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—urinary bladder cancer	1.05e-05	0.000183	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	1.04e-05	0.000181	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.01e-05	0.000176	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.01e-05	0.000176	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—urinary bladder cancer	1.01e-05	0.000176	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HRAS—urinary bladder cancer	1.01e-05	0.000175	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—RRM2—urinary bladder cancer	1e-05	0.000175	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.88e-06	0.000172	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—CREBBP—urinary bladder cancer	9.76e-06	0.00017	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GSTP1—urinary bladder cancer	9.74e-06	0.00017	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HRAS—urinary bladder cancer	9.64e-06	0.000168	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IGF1—urinary bladder cancer	9.64e-06	0.000168	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NAT2—urinary bladder cancer	9.52e-06	0.000166	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.42e-06	0.000164	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	9.35e-06	0.000163	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ENO2—urinary bladder cancer	9.35e-06	0.000163	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CREBBP—urinary bladder cancer	9.33e-06	0.000163	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—HPGDS—urinary bladder cancer	9.3e-06	0.000162	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ENO2—urinary bladder cancer	9.3e-06	0.000162	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.3e-06	0.000162	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NQO1—urinary bladder cancer	9.27e-06	0.000162	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.25e-06	0.000161	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IGF1—urinary bladder cancer	9.22e-06	0.000161	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—EGFR—urinary bladder cancer	9.17e-06	0.00016	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	9.07e-06	0.000158	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—TYMS—urinary bladder cancer	9.05e-06	0.000158	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTT1—urinary bladder cancer	9.02e-06	0.000157	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GSTM1—urinary bladder cancer	8.95e-06	0.000156	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NCOR1—urinary bladder cancer	8.95e-06	0.000156	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.93e-06	0.000156	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.88e-06	0.000155	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—RHOA—urinary bladder cancer	8.83e-06	0.000154	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—KRAS—urinary bladder cancer	8.66e-06	0.000151	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GPX1—urinary bladder cancer	8.57e-06	0.000149	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NCOR1—urinary bladder cancer	8.48e-06	0.000148	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.45e-06	0.000147	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—RHOA—urinary bladder cancer	8.44e-06	0.000147	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	8.43e-06	0.000147	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ERCC2—urinary bladder cancer	8.41e-06	0.000147	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—RRM2—urinary bladder cancer	8.22e-06	0.000143	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	8.1e-06	0.000141	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERCC2—urinary bladder cancer	7.97e-06	0.000139	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—MTHFR—urinary bladder cancer	7.91e-06	0.000138	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.84e-06	0.000137	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ERBB2—urinary bladder cancer	7.82e-06	0.000136	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTP1—urinary bladder cancer	7.73e-06	0.000135	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	7.61e-06	0.000133	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ENO2—urinary bladder cancer	7.61e-06	0.000133	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.57e-06	0.000132	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NQO1—urinary bladder cancer	7.54e-06	0.000131	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NQO1—urinary bladder cancer	7.5e-06	0.000131	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MTHFR—urinary bladder cancer	7.5e-06	0.000131	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.48e-06	0.00013	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TERT—urinary bladder cancer	7.47e-06	0.00013	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IL2—urinary bladder cancer	7.41e-06	0.000129	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	7.38e-06	0.000129	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HRAS—urinary bladder cancer	7.36e-06	0.000128	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.32e-06	0.000128	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.27e-06	0.000127	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.27e-06	0.000127	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—TYMS—urinary bladder cancer	7.19e-06	0.000125	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTM1—urinary bladder cancer	7.1e-06	0.000124	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NCOR1—urinary bladder cancer	7.1e-06	0.000124	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL2—urinary bladder cancer	7.08e-06	0.000124	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCND1—urinary bladder cancer	6.91e-06	0.00012	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FGFR3—urinary bladder cancer	6.86e-06	0.00012	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GPX1—urinary bladder cancer	6.8e-06	0.000119	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP9—urinary bladder cancer	6.7e-06	0.000117	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDKN1A—urinary bladder cancer	6.68e-06	0.000116	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ERCC2—urinary bladder cancer	6.68e-06	0.000116	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTEN—urinary bladder cancer	6.67e-06	0.000116	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—EP300—urinary bladder cancer	6.65e-06	0.000116	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	6.63e-06	0.000116	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—SRC—urinary bladder cancer	6.46e-06	0.000113	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PPARG—urinary bladder cancer	6.41e-06	0.000112	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.38e-06	0.000111	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EP300—urinary bladder cancer	6.36e-06	0.000111	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.34e-06	0.000111	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	6.29e-06	0.00011	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—MTHFR—urinary bladder cancer	6.28e-06	0.000109	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTP1—urinary bladder cancer	6.25e-06	0.000109	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SRC—urinary bladder cancer	6.18e-06	0.000108	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CREBBP—urinary bladder cancer	6.16e-06	0.000107	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NQO1—urinary bladder cancer	6.14e-06	0.000107	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.08e-06	0.000106	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.05e-06	0.000105	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.95e-06	0.000104	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TYMS—urinary bladder cancer	5.85e-06	0.000102	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CREBBP—urinary bladder cancer	5.84e-06	0.000102	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TYMS—urinary bladder cancer	5.81e-06	0.000101	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	5.78e-06	0.000101	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	5.78e-06	0.000101	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	5.78e-06	0.000101	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTM1—urinary bladder cancer	5.75e-06	0.0001	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NCOR1—urinary bladder cancer	5.75e-06	0.0001	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MYC—urinary bladder cancer	5.54e-06	9.66e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GPX1—urinary bladder cancer	5.53e-06	9.65e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—EP300—urinary bladder cancer	5.51e-06	9.61e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GPX1—urinary bladder cancer	5.5e-06	9.59e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	5.43e-06	9.47e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EGFR—urinary bladder cancer	5.42e-06	9.45e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ERCC2—urinary bladder cancer	5.4e-06	9.42e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—KRAS—urinary bladder cancer	5.35e-06	9.33e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—RHOA—urinary bladder cancer	5.28e-06	9.21e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.19e-06	9.05e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KRAS—urinary bladder cancer	5.12e-06	8.92e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	5.12e-06	8.92e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	5.11e-06	8.9e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PPARG—urinary bladder cancer	5.09e-06	8.87e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—MTHFR—urinary bladder cancer	5.08e-06	8.85e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTGS2—urinary bladder cancer	5.04e-06	8.79e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.95e-06	8.63e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CREBBP—urinary bladder cancer	4.89e-06	8.52e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERBB2—urinary bladder cancer	4.89e-06	8.52e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TYMS—urinary bladder cancer	4.76e-06	8.3e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—urinary bladder cancer	4.76e-06	8.29e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	4.7e-06	8.2e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	4.7e-06	8.2e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—urinary bladder cancer	4.55e-06	7.93e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HRAS—urinary bladder cancer	4.55e-06	7.93e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GPX1—urinary bladder cancer	4.5e-06	7.85e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	4.42e-06	7.71e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTEN—urinary bladder cancer	4.4e-06	7.67e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HRAS—urinary bladder cancer	4.35e-06	7.58e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—EP300—urinary bladder cancer	4.2e-06	7.31e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN1A—urinary bladder cancer	4.18e-06	7.29e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PTEN—urinary bladder cancer	4.17e-06	7.27e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	4.16e-06	7.25e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PPARG—urinary bladder cancer	4.14e-06	7.22e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PPARG—urinary bladder cancer	4.12e-06	7.18e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	3.98e-06	6.94e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EP300—urinary bladder cancer	3.98e-06	6.93e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CREBBP—urinary bladder cancer	3.96e-06	6.9e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SRC—urinary bladder cancer	3.87e-06	6.74e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PTEN—urinary bladder cancer	3.49e-06	6.09e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MYC—urinary bladder cancer	3.47e-06	6.04e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EGFR—urinary bladder cancer	3.39e-06	5.91e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PPARG—urinary bladder cancer	3.37e-06	5.88e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—EP300—urinary bladder cancer	3.33e-06	5.81e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	3.26e-06	5.68e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS2—urinary bladder cancer	3.24e-06	5.65e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	3.24e-06	5.65e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KRAS—urinary bladder cancer	3.2e-06	5.58e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTEN—urinary bladder cancer	2.84e-06	4.95e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTEN—urinary bladder cancer	2.83e-06	4.93e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HRAS—urinary bladder cancer	2.72e-06	4.74e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—EP300—urinary bladder cancer	2.71e-06	4.72e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—EP300—urinary bladder cancer	2.69e-06	4.7e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.65e-06	4.62e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTEN—urinary bladder cancer	2.31e-06	4.03e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.21e-06	3.84e-05	CbGpPWpGaD
